Total Funding
75
48
Total FundingSeries C raised
Growth Score
-3 pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
24788
DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.
- Jordi Carrera: Co-Founder & Chief Executive OfficerPast Role: STAT-Dx, Chief Executive Officer
- Rafel Bru: Co-Founder & Chief Technology OfficerPast Role: STAT-Dx, Director of Engineering
About the Company
DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functional
status on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
